MENU
ARX
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ARX stock forecast, quote, news & analysis

Accelerant Holdings operates as a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
ARX
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for ARX with price predictions
Oct 21, 2026

ARX's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for ARX moved out of overbought territory on October 20, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 instances where the indicator moved out of the overbought zone. In 6 of the 7 cases the stock moved lower in the days that followed. This puts the odds of a move down at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 9 of 11 cases where ARX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

ARX broke above its upper Bollinger Band on October 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on ARX as a result. In 11 of 15 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

Following a +0.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARX advanced for three days, in 48 of 61 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 19 of 39 cases where ARX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 49%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. ARX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.979) is normal, around the industry mean (2.582). P/E Ratio (-3.134) is within average values for comparable stocks, (17.872). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (3.766) is also within normal values, averaging (2.968).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 14.21B. The market cap for tickers in the group ranges from 3.03K to 90.94B. MRSH holds the highest valuation in this group at 90.94B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was 9%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 15%. XHG experienced the highest price growth at 91%, while ZBAO experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 55
SMR Rating: 70
Profit Risk Rating: 87
Seasonality Score: 12 (-100 ... +100)